AIMSAcuitas Small Cap Active ETF
The schedule
- Wed21Oct
(Driven by TFIN) Market evaluation of Q3 2026 performance with intense focus on TriumphPay volume and net interest margin execution.
- Tue8Dec
(Driven by LGND) Ligand is expected to announce new investment opportunities or strategic initiatives that could impact its business direction and financial performance. This event is significant as it may signal the company's growth strategy and future projects. Investors will be interested in the details of these announcements to assess the company's potential for expansion and profitability. The announcement is likely to influence the stock price, with a moderate impact based on historical trends.
- Wed16Dec
(Driven by TFIN) Assimilation of the final FOMC decision of the year, testing the net interest margin resilience for regional lenders.
- Tue9Feb
(Driven by LGND) The company is set to release its quarterly earnings report, which will include guidance for the upcoming fiscal period. This event is crucial as it provides insight into the company's financial performance and future outlook. Investors will closely watch the results to gauge the company's health and potential for growth. The earnings release is expected to have a significant impact on the stock price, with historical data indicating a balanced mix of positive and negative outcomes.
- Wed31Mar
(Driven by CNOB) An anticipated sector-wide regulatory stress test and market reassessment of regional bank CRE exposures, specifically focusing on office and multifamily loan refinancing.
- Wed21Apr
(Driven by TFIN) Q1 2027 earnings print, historically presenting seasonal hurdles for freight volume metrics.
- Tue15Jun
(Driven by BFST) Market assimilation of mid-year Federal Reserve dot plots and structural interest rate positioning. Favorable stabilization targets $36.00, while a hawkish shock could pressure shares to $31.00.
- Tue15Jun
(Driven by TFIN) Expected mid-year corporate update on Tier-1 broker integrations and market rate intelligence expansion.
- Wed21Jul
(Driven by TFIN) Q2 2027 earnings release, focusing on sequential GPV improvement and margin stabilization.
Past
- Fri31Jul
Actual outcome: Bull
MCB reported strong Q2 earnings that surpassed expectations, driven by significant net interest margin (NIM) expansion and resilient credit quality. The positive results and reassuring forward guidance validated the market's high expectations, propelling the stock to reach its bull target.
MCB reported strong Q2 earnings that surpassed expectations, driven by significant net interest margin (NIM) expansion and resilient credit quality. The positive results and reassuring forward guidance validated the market's high expectations, propelling the stock to reach its bull target.